Posts by Tracey G. Simon, MD
-
Physical Activity Reduces Chronic Liver Disease Mortality Risk
Massachusetts General Hospital researchers have demonstrated for the first time that exercise is an independent determinant of mortality from cirrhosis and its complications.
-
Epoxyeicosatrienoic Acid May Be a Biomarker for Nonalcoholic Steatohepatitis
Massachusetts General Hospital researchers have identified a non-invasive means to identify which patients with nonalcoholic fatty liver disease are at high risk of nonalcoholic steatohepatitis.
-
Daily Aspirin Use Tied to Lower Risk of Fibrosis Progression in Nonalcoholic Fatty Liver Disease
Long-term data from a prospective cohort of patients with nonalcoholic fatty liver disease, who reported their aspirin use regularly, provides evidence of hepatoprotective effects of daily aspirin.
Biography
Tracey Simon, MD, MPH, is a hepatologist in the Division of Gastroenterology, and an Instructor of Medicine at Harvard Medical School. Dr. Simon treats all forms of liver disease, and specializes in the diagnosis and management of non-alcoholic fatty liver disease. Her research focuses on developing strategies to prevent cirrhosis, and reduce the risk for hepatocellular carcinoma.
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.
